Skip to main content

MoneyWorks4Me

Earum Pharmaceuticals informs about disclosure

27 Apr 2022 Evaluate

Earum Pharmaceuticals has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Payal B Patel.

The above information is a part of company’s filings submitted to BSE.

Peers